Omkar Pharmachem Q1 FY27 results: loss of Rs 1 lakh vs profit last year

Net loss reportedRevenue declinedResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.5%Reaction day

₹15.71

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-4.6% vs market

Commodity Chemicals peers, median of 53sector+0.3%-4.9% vs sector

On the reaction day the stock moved 4.6 pts less than Nifty Microcap 250 and 4.9 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.5+0.1-4.6+0.3-4.9

Next day

-9.1+0.2-9.3-0.1-9.0

-13.6+0.6-14.2-1.2-12.4

-17.9-0.0-17.9-1.6-16.3

-22.0+0.5-22.5+0.1-22.0

-25.8+0.8-26.6-0.9-24.9

-26.2+0.6-26.7-1.3-24.9

15d

-41.1+1.3-42.3-0.4-40.7

-50.4-1.4-49.1-0.1-50.3

—-0.6—-0.5—

—————

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 53Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Omkar Pharmachem reported Q1 FY27 (ended 30 June 2026) unaudited results. Net sales stood at zero; other operating income fell to Rs 9 lakh from Rs 13.5 lakh YoY. Total expenses rose to Rs 10 lakh, leading to a loss of Rs 1 lakh versus a profit of Rs 2.66 lakh in Q1 FY26. EPS turned negative at minus 0.0099. Other equity remains negative at minus Rs 52.82 lakh.

Likely market impact

Company swung to loss in Q1 with declining income, zero core sales, and negative reserves — weak fundamentals.